CYP3A4 and CYP3A5 Genotypes, Haplotypes, and Risk of Prostate Cancer

Sarah J. Plummer; David V. Conti; Pamela L. Paris; Anthony P. Curran; Graham Casey; John S. Witte

AACR Publications

AACR logo

Register
Log in
My Cart

Main menu

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

AACR Publications

User menu

Register
Log in
My Cart

Search

Search for this keyword

Advanced search

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

Short Communications

CYP3A4 and CYP3A5 Genotypes, Haplotypes, and Risk of Prostate Cancer

Sarah J. Plummer, David V. Conti, Pamela L. Paris, Anthony P. Curran, Graham Casey and John S. Witte

Sarah J. Plummer

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

David V. Conti

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Pamela L. Paris

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anthony P. Curran

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Graham Casey

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

John S. Witte

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

DOI: Published September 2003

Article
Figures & Data
Info & Metrics
PDF

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: September 2003 to March 2021

	Abstract	Full-text HTML	PDF
Total	2178	13648	2399

Cited By

Article Information

Volume 12, Issue 9, pp. 928-932

PubMed

14504207

Published By

American Association for Cancer Research

Print ISSN

1055-9965

Online ISSN

1538-7755

History

Received September 30, 2002
Revision received March 10, 2003
Accepted May 27, 2003
Published first September 22, 2003.

Author Information

Sarah J. Plummer2,
David V. Conti2,,3,
Pamela L. Paris4,
Anthony P. Curran,
Graham Casey, and
John S. Witte5

Department of Cancer Biology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio [S. J. P., P. L. P., A. P. C., G. C.], and Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio 44106-4945 [D. V. C., J. S. W.]

View Full Text

PreviousNext

Cancer Epidemiology Biomarkers & Prevention: 12 (9)

September 2003
Volume 12, Issue 9

Table of Contents

Search for this keyword

View this article with LENS

Open full page PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following CYP3A4 and CYP3A5 Genotypes, Haplotypes, and Risk of Prostate Cancer

Message Subject (Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention

Message Body (Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

CYP3A4 and CYP3A5 Genotypes, Haplotypes, and Risk of Prostate Cancer